SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003379
Filing Date
2017-05-03
Accepted
2017-05-03 16:09:36
Documents
69
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20170331x10q.htm 10-Q 1480800
2 EX-10.3 vvus-20170331ex103a245ce.htm EX-10.3 108206
3 EX-31.1 vvus-20170331ex31184ae02.htm EX-31.1 18611
4 EX-31.2 vvus-20170331ex312e4236a.htm EX-31.2 19958
5 EX-32 vvus-20170331xex32.htm EX-32 14819
  Complete submission text file 0001558370-17-003379.txt   5257811

Data Files

Seq Description Document Type Size
6 EX-101.INS vvus-20170331.xml EX-101.INS 998395
7 EX-101.SCH vvus-20170331.xsd EX-101.SCH 40583
8 EX-101.CAL vvus-20170331_cal.xml EX-101.CAL 48647
9 EX-101.DEF vvus-20170331_def.xml EX-101.DEF 109934
10 EX-101.LAB vvus-20170331_lab.xml EX-101.LAB 331085
11 EX-101.PRE vvus-20170331_pre.xml EX-101.PRE 247317
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 17809225
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1